BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11049735)

  • 1. Neurokinin mediation of edema and inflammation.
    Campos MM; Calixto JB
    Neuropeptides; 2000 Oct; 34(5):314-22. PubMed ID: 11049735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin A and neurokinin B in the human retina.
    Schmid E; Leierer J; Kieselbach G; Teuchner B; Kralinger M; Fischer-Colbrie R; Krause JE; Nguyen QA; Haas G; Stemberger K; Troger J
    Peptides; 2006 Dec; 27(12):3370-6. PubMed ID: 16956695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical study on three peptidergic terminals in nasal mucosa in a rat AR model].
    Zhao C; Tao Z; Xiao J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):224-6. PubMed ID: 9642348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of tachykinins in the cat spinal cord.
    Sánchez L; Coveñas R; Aguirre JA; Narváez JA; Gómez A; Tramu G
    Arch Ital Biol; 2005 Feb; 143(1):29-50. PubMed ID: 15844667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of neurokinin B and hemokinin-1 in human immune cells.
    Klassert TE; Pinto F; Hernández M; Candenas ML; Hernández MC; Abreu J; Almeida TA
    J Neuroimmunol; 2008 May; 196(1-2):27-34. PubMed ID: 18400309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in tachykinin--ergic nerve terminal densities in rat nasal mucosa during hypersensitivity.
    Zhao C; Tao Z; Xiao J; Zhao S; Qiao J
    Chin Med J (Engl); 1997 Feb; 110(2):134-8. PubMed ID: 9594285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.
    Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP
    Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retina.
    Teuchner B; Dimmer A; Troger J; Fischer-Colbrie R; Schmid E; Kieselbach G; Dietrich H; Bechrakis N
    Regul Pept; 2010 Nov; 165(1):123-7. PubMed ID: 20138192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for tachykinins in female mouse and rat reproductive function.
    Pintado CO; Pinto FM; Pennefather JN; Hidalgo A; Baamonde A; Sanchez T; Candenas ML
    Biol Reprod; 2003 Sep; 69(3):940-6. PubMed ID: 12773411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Ca2+ signaling in tachykinin-mediated contractile responses in swine trachea.
    Lin YR; Kao PC; Chan MH
    J Biomed Sci; 2005; 12(3):547-58. PubMed ID: 15971006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important roles of tachykinins in the development of allergic nasal hyperresponsiveness in guinea-pigs.
    Nabe T; Tsuzuike N; Ohtani Y; Mizutani N; Watanabe S; Fujii M; Yoshimura M; Nagasawa M; Kohno S
    Clin Exp Allergy; 2009 Jan; 39(1):138-46. PubMed ID: 18778270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The neurogenic mechanisms of ocular inflammation and their modulation under local treatment with indomethacin].
    Bulboacă A; Pop R; Bulboacă A
    Oftalmologia; 2000; 50(1):25-9. PubMed ID: 11021103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and biochemical evidence for multiple types of tachykinin NK2 receptors.
    Buck SH; Fanger BO; van Giersbergen PL
    Ann N Y Acad Sci; 1991; 632():112-5. PubMed ID: 1719859
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurokinin a is a main constituent of sensory neurons innervating the anterior segment of the eye.
    Schmid E; Leierer J; Doblinger A; Laslop A; Fischer-Colbrie R; Humpel C; Theodorsson E; Teuchner B; Lalehabbasi D; Dragosits E; Kunze C; Philipp W; Göttinger W; Troger J
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):268-74. PubMed ID: 15623783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
    Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
    Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the understanding of sensory neuropeptides.
    De Swert KO; Joos GF
    Eur J Pharmacol; 2006 Mar; 533(1-3):171-81. PubMed ID: 16464447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin B signaling in puberty: human and animal studies.
    Topaloglu AK
    Mol Cell Endocrinol; 2010 Aug; 324(1-2):64-9. PubMed ID: 20176081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective and combined neurokinin receptor antagonists.
    Gerspacher M
    Prog Med Chem; 2005; 43():49-103. PubMed ID: 15850823
    [No Abstract]   [Full Text] [Related]  

  • 19. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
    Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain.
    Gradl G; Finke B; Schattner S; Gierer P; Mittlmeier T; Vollmar B
    Neuroscience; 2007 Sep; 148(3):757-65. PubMed ID: 17686587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.